Aspiration & Values
We want to change the way iron deficiency is prevented and treated.
Our relationships, our responsiveness
Our culture is enriched with a genuine appetite to make a mark that goes far beyond doing good in all our relationships – with patients and healthcare professionals, as well as our society, environment, partners, and colleagues. We take pride in our responsiveness, which is fuelled by a short chain of command, accessibility, and a total elimination of silo-thinking across all aspects of our organisation.
Since we believe that the force of competition drives progress, we are entrepreneurial and competitive by nature, and we challenge ourselves to work smarter, faster, and more collaboratively, continuously setting new standards.
Our contribution
We have been charting considerable growth over the past few years and today we have a presence in a total of 40 countries. We are proud of our contributions to healthy communities, sustainable societies, an inclusive workplace, and an ethical marketplace.
Committed to quality since 1965
Pharmacosmos was established in 1965 by Henry Christensen MD, PhD, who was succeeded by his youngest son Lars Christensen, MD, as CEO in 1994. The company has since its establishment remained an independent family-owned company.
Explore more about pharmacosmos
We are a global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
